OBJECTIVE: Obesity increases endometrial cancer risk, yet its impact on disease stage and grade is unclear. We prospectively examined the effects of body mass index (BMI) and waist-to-hip ratio (WHR) on incidence, stage, and grade of endometrial cancer. METHODS: We studied 86937 postmenopausal women enrolled in the Women's Health Initiative. Height, weight, and waist and hip circumference were measured at baseline. Endometrial cancer cases were adjudicated by trained physicians and pathology reports were used to determine stage and grade. Cox proportional hazards models generated hazard ratios (HR) for associations between BMI and WHR and risk of endometrial cancer. Logistic regression was used to evaluate associations between BMI and WHR and disease stage and grade. RESULTS: During a mean 7.8 (standard deviation 1.6) years of follow-up, 806 women were diagnosed with endometrial cancer. Although incidence was higher among Whites, stage and grade were similar between Whites and Blacks. Elevated BMI (HR 1.76, 95% confidence interval [CI] 1.41-2.19) and WHR (HR 1.33, 95% CI 1.04-1.70) increased endometrial cancer risk when comparing women in the highest and lowest categories. No associations were observed between BMI or WHR and disease stage or grade. CONCLUSIONS: Obesity increases endometrial cancer risk independent of other factors but is not associated with stage or grade of disease. These findings support and validate previous reports. Future research should evaluate the impact of obesity on racial disparities in endometrial cancer survival.
OBJECTIVE:Obesity increases endometrial cancer risk, yet its impact on disease stage and grade is unclear. We prospectively examined the effects of body mass index (BMI) and waist-to-hip ratio (WHR) on incidence, stage, and grade of endometrial cancer. METHODS: We studied 86937 postmenopausal women enrolled in the Women's Health Initiative. Height, weight, and waist and hip circumference were measured at baseline. Endometrial cancer cases were adjudicated by trained physicians and pathology reports were used to determine stage and grade. Cox proportional hazards models generated hazard ratios (HR) for associations between BMI and WHR and risk of endometrial cancer. Logistic regression was used to evaluate associations between BMI and WHR and disease stage and grade. RESULTS: During a mean 7.8 (standard deviation 1.6) years of follow-up, 806 women were diagnosed with endometrial cancer. Although incidence was higher among Whites, stage and grade were similar between Whites and Blacks. Elevated BMI (HR 1.76, 95% confidence interval [CI] 1.41-2.19) and WHR (HR 1.33, 95% CI 1.04-1.70) increased endometrial cancer risk when comparing women in the highest and lowest categories. No associations were observed between BMI or WHR and disease stage or grade. CONCLUSIONS:Obesity increases endometrial cancer risk independent of other factors but is not associated with stage or grade of disease. These findings support and validate previous reports. Future research should evaluate the impact of obesity on racial disparities in endometrial cancer survival.
Authors: J David Curb; Anne McTiernan; Susan R Heckbert; Charles Kooperberg; Janet Stanford; Michael Nevitt; Karen C Johnson; Lori Proulx-Burns; Lisa Pastore; Michael Criqui; Sandra Daugherty Journal: Ann Epidemiol Date: 2003-10 Impact factor: 3.797
Authors: A R Folsom; L H Kushi; K E Anderson; P J Mink; J E Olson; C P Hong; T A Sellers; D Lazovich; R J Prineas Journal: Arch Intern Med Date: 2000-07-24
Authors: B Anderson; J P Connor; J I Andrews; C S Davis; R E Buller; J I Sorosky; J A Benda Journal: Am J Obstet Gynecol Date: 1996-04 Impact factor: 8.661
Authors: R J Barrett; L C Harlan; M N Wesley; H A Hill; V W Chen; L A Clayton; H L Kotz; J W Eley; S J Robboy; B K Edwards Journal: Am J Obstet Gynecol Date: 1995-08 Impact factor: 8.661
Authors: H A Hill; R J Coates; H Austin; P Correa; S J Robboy; V Chen; L A Click; R J Barrett; J G Boyce; H L Kotz Journal: Gynecol Oncol Date: 1995-02 Impact factor: 5.482
Authors: Jason D Wright; Jessica Fiorelli; Peter B Schiff; William M Burke; Amanda L Kansler; Carmel J Cohen; Thomas J Herzog Journal: Cancer Date: 2009-03-15 Impact factor: 6.860
Authors: Amy S Joehlin-Price; Julie A Stephens; Jianying Zhang; Floor J Backes; David E Cohn; Adrian A Suarez Journal: Cancer Epidemiol Biomarkers Prev Date: 2015-12-18 Impact factor: 4.254
Authors: Rhonda Arthur; Theodore M Brasky; Tracy E Crane; Ashley S Felix; Andrew M Kaunitz; Aladdin H Shadyab; Lihong Qi; Sylvia Wassertheil-Smoller; Thomas E Rohan Journal: Am J Epidemiol Date: 2019-02-01 Impact factor: 4.897
Authors: Amy S Joehlin-Price; Kelsey E McHugh; Julie A Stephens; Zaibo Li; Floor J Backes; David E Cohn; David W Cohen; Adrian A Suarez Journal: Am J Surg Pathol Date: 2017-01 Impact factor: 6.394
Authors: Amy S Joehlin-Price; Carmen M Perrino; Julie Stephens; Floor J Backes; Paul J Goodfellow; David E Cohn; Adrian A Suarez Journal: Gynecol Oncol Date: 2014-01-17 Impact factor: 5.482
Authors: Melina Arnold; Heinz Freisling; Rachael Stolzenberg-Solomon; Frank Kee; Mark George O'Doherty; José Manuel Ordóñez-Mena; Tom Wilsgaard; Anne Maria May; Hendrik Bas Bueno-de-Mesquita; Anne Tjønneland; Philippos Orfanos; Antonia Trichopoulou; Paolo Boffetta; Freddie Bray; Mazda Jenab; Isabelle Soerjomataram Journal: Eur J Epidemiol Date: 2016-06-14 Impact factor: 8.082
Authors: Ernest K Amankwah; Christine M Friedenreich; Anthony M Magliocco; Rollin Brant; Kerry S Courneya; Thomas Speidel; Wahida Rahman; Annie R Langley; Linda S Cook Journal: Am J Epidemiol Date: 2013-05-14 Impact factor: 4.897
Authors: Stephanie M George; Rachel Ballard; James M Shikany; Tracy E Crane; Marian L Neuhouser Journal: Ann Epidemiol Date: 2015-06-05 Impact factor: 3.797
Authors: Marisa A Bittoni; James L Fisher; Jeffrey M Fowler; George L Maxwell; Electra D Paskett Journal: Cancer Epidemiol Biomarkers Prev Date: 2012-11-01 Impact factor: 4.254